Progress in our understanding of the pathogenesis of severe sepsis has been constant over the past two decades, and is now beginning to lead to new therapeutic approaches. During the previous funding period, we demonstrated that targeted (but not systemic) expression of first generation adenoviral (Ad) vectors expressing IL-10 could improve outcome in several murine models of sepsis. Importantly, the use of Ad has provided a unique tool to modulate dendritic cell (DC) phenotype, deliver IL-10 locally, and modify the sepsis response. Although we (and others) have demonstrated that the loss of DCs from lymphoid tissues is a consequence of sepsis, its causative relationship to outcome has not been confirmed until recently. In preliminary studies, we have demonstrated that myeloid and lymphoid DC depletion is associated with an adverse outcome in murine sepsis, whereas modifying the phenotype of DCs both in vivo and ex vivo by autocrine production of IL-10 can improve outcome. This continuing renewal seeks to identify the mechanistic basis for these observations, as well as the overall importance of DCs in the sepsis response. Our overarching hypothesis is that modulation of DC function bv adenoviral delivery of IL-10 can improve outcome in sepsis bv altering the interactions between DCs and T-cell and natural killer (NK) cell populations in Iymphatic tissues. The two specific aims are focused on determining whether modifying DC number and function with Ad expressing IL-10 impacts outcome through alterations in the induction of T-cell apoptosis. The generation of regulatory T cell populations, and NK and NK-Tcell interactions. Using a murine model of generalized peritonitis (cecal ligation and puncture), and transgenic mice that can be depleted of CD11c+ cells, or transgenic mice lacking IL-10 or CD25<7, as well as reconstitution experiments with Ad-transduced DCs, we intend to explore the mechanisms by which modification of DC status and function alters outcome to sepsis. Not only will these studies provide valuable preclinical information about the feasibility of ex vivo Ad transfections schemes in sepsis and acute inflammation, but will also provide essential information about the role of the DC in the successful host response to sepsis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM063041-06
Application #
7102717
Study Section
Special Emphasis Panel (ZRG1-SBIB-G (02))
Program Officer
Somers, Scott D
Project Start
2001-04-01
Project End
2009-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
6
Fiscal Year
2006
Total Cost
$271,730
Indirect Cost
Name
University of Florida
Department
Surgery
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Cuenca, Alex G; Delano, Matthew J; Kelly-Scumpia, Kindra M et al. (2010) Cecal ligation and puncture. Curr Protoc Immunol Chapter 19:Unit 19.13
Efron, Philip A; Matsumoto, Tadashi; McAuliffe, Priscilla F et al. (2009) Major hepatectomy induces phenotypic changes in circulating dendritic cells and monocytes. J Clin Immunol 29:568-81
Tschoeke, S K; Oberholzer, C; LaFace, D et al. (2008) Endogenous IL-10 regulates sepsis-induced thymic apoptosis and improves survival in septic IL-10 null mice. Scand J Immunol 68:565-71
Matsumoto, Tadashi; O'Malley, Kerri; Efron, Philip A et al. (2006) Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 140:793-802
Matsumoto, Tadashi; Efron, Philip A; Tsujimoto, Hironori et al. (2005) Splenic transposition is superior to caudal shunt as a model of murine total hepatic ischemia. Lab Invest 85:90-8
Tsujimoto, Hironori; Ono, Satoshi; Majima, Takashi et al. (2005) Neutrophil elastase, MIP-2, and TLR-4 expression during human and experimental sepsis. Shock 23:39-44
Scumpia, Philip O; Moldawer, Lyle L (2005) Biology of interleukin-10 and its regulatory roles in sepsis syndromes. Crit Care Med 33:S468-71
Efron, Philip A; Tsujimoto, Hironori; Bahjat, Frances R et al. (2005) Differential maturation of murine bone-marrow derived dendritic cells with lipopolysaccharide and tumor necrosis factor-alpha. J Endotoxin Res 11:145-60
Oberholzer, Andreas; Oberholzer, Caroline; Efron, Philip A et al. (2005) Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis. Shock 23:507-15
Tsujimoto, Hironori; Uchida, Takefumi; Efron, Philip A et al. (2005) Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions. J Leukoc Biol 78:888-97

Showing the most recent 10 out of 13 publications